A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures

Health Technology Assessment

Volumn 18, Issue 34, 2014, Pages 1-188

  Brazier, John ^a   Connell, Janice ^a   Papaioannou, Diana ^a   Mukuria, Clara ^a   Mulhern, Brendan ^a   Peasgood, Tessa ^a   Jones, Myfawnwy Lloyd ^a   Paisley, Suzy ^a   O'Cathain, Alicia ^a   Barkham, Michael ^a   Knapp, Martin ^b   Byford, Sarah ^b   Gilbody, Simon ^c   Parry, Glenys ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL OUTCOMES IN ROUTINE EVALUATION OUTCOME MEASURE; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONVERGENT VALIDITY; DEPRESSION; DISCRIMINANT VALIDITY; EQ-5D; GENERAL HEALTH QUESTIONNAIRE; GENERALISED ANXIETY DISORDER ASSESSMENT; HOPELESSNESS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MENTAL DISEASE; PANIC; PATIENT AUTONOMY; PATIENT DECISION MAKING; PATIENT HEALTH QUESTIONNAIRE; PATIENT SATISFACTION; PERSONALITY DISORDER; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGICAL WELL BEING; PSYCHOMETRY; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUESTIONNAIRE; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SHORT FORM 12; SHORT FORM 36; SHORT FORM 6D; SYSTEMATIC REVIEW; HEALTH STATUS; MENTAL HEALTH; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT; PROCEDURES; PSYCHOLOGY; QUALITY ADJUSTED LIFE YEAR; REGRESSION ANALYSIS; REPRODUCIBILITY; UNITED KINGDOM;

GREAT BRITAIN; HEALTH STATUS; HUMANS; MENTAL DISORDERS; MENTAL HEALTH; MENTAL HEALTH SERVICES; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84901606990     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta18340     Document Type: Article

References (253)

1. Gilbody S, Sheldon T, House A. Outcomes research in mental health. Systematic review. Br J Psychiatry 2003;181:8-16. http://dx.doi.org/10.1192/bjp.181.1.8
2. Gladis MM, Gosch EA, Dishuk NM, Crits-Cristoph P. Quality of life: expanding the scope of clinical significance. J Consult Clin Psychol 1999;67:320-31. http://dx.doi.org/10.1037//0022-006X.67.3.320
3. Pharmaceutical Benefits Advisory Committee. Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee: Australia. Department of Health (Australia); 2008. URL: www.health.gov.au/internet/main/publishing.Nsf/content/pbacguidelines-index (accessed 2 January 2014).
4. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). General Methods for the Assessment of the Relation of Benefits to Costs: Germany. ISPOR; 2009. URL: www.ispor. org/PEguidelines/countrydet.asp?c=9&t=1 (accessed 2 January 2014).
5. Health Information and Quality Authority (HIQA). Guidelines for the Economic Evaluation of Health Technologies In Ireland. HIQA; 2010. URL: www.hiqa.ie/publication/guidelines-economicevaluation-health-technologies-ireland (accessed 2 January 2014).
6. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). China Guidelines for Pharmacoeconomic Evaluations. ISPOR; 2011. URL: www.ispor.org/PEguidelines/countrydet. asp?c=28&t=4 (accessed 2 January 2014).
7. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Health Technology Assessment Guideline: Thailand. ISPOR; 2008. URL: www.ispor.org/PEguidelines/countrydet.asp? c=36&t=2 (accessed 2 January 2014).
8. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Pharmacoeconomic Evaluations in Belgium. ISPOR; 2008. URL: www.ispor.org/PEguidelines/ countrydet.asp?c=3&t=1 (accessed 2 January 2014).
9. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Spanish Recommendations on Economic Evaluation of Health Technologies (Spanish version 2009). ISPOR; 2009. URL: www.ispor.org/PEguidelines/countrydet.asp?c=20&t=4 (accessed 2 January 2014).
10. International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Guidelines on how to conduct pharmacoeconomic analyses: Norway. ISPOR; 2012. URL: www.ispor.org/ PEguidelines/countrydet.asp?c=15&t=1 (accessed 2 January 2014).
11. Brazier J. Is the EQ-5D fit for purpose in mental health? Br J Psychiatry 2010;197:348-9. http://dx.doi.org/10.1192/bjp.bp.110.082453
12. Saarni S, Viertio D, Perala J, Koskinen S, Lonqvist J, Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry 2010;197:386-94. http://dx.doi.org/10.1192/bjp.bp.109.076489
13. Brazier J, Ratcliffe J, Tsuchiya A, Solomon J. Measuring and Valuing Health for Economic Evaluation. Oxford: Oxford University Press; 2007.
14. Williams A. Economics of coronary artery bypass grafting. Br Med J 1985;291:326-9. http://dx.doi.org/10.1136/bmj.291.6491.326
15. Dolan P. Modelling valuations for EuroQol health states. Med Care 1997;35:1095-108. http://dx.doi.org/10.1097/00005650-199711000-00002
16. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92. http://dx.doi.org/10.1016/S0167-6296(01)00130-8
17. Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, De Pauuw D, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care 2002;40:113-28. http://dx.doi.org/10.1097/00005650-200202000-00006
18. Kaplan R, Bush JW. Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982;1:61-80. http://dx.doi.org/10.1037/0278-6133.1.1.61
19. Ware JE, Snow KK, Kolinski M, Gandeck B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
20. Brazier J, Deverill M, Harper R, Booth A. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999;3(9).
21. Brazier J, Roberts J. Estimating a preference-based index from the SF-12. Med Care 2004;42:851-9.
22. Brown J, Bowling A, Flynn TN. Models of Quality of Life. A Taxonomy and Systematic Review of the Literature. European Forum on Population Ageing Research/Quality of Life; 2004. URL: http://eprints.kingston.ac.uk/17177 (accessed 2 January 2014).
23. Johansson S. Conceptualising and measuring quality of life for national policy: from the Swedish Level of Living Survey to an epistemology of the democratic process. Soc Indic Res 2002;58:13-32.
24. Veenhoven R. Why social policy needs subjective indicators. Social Indic Res 2002;58:33-45. http://dx.doi.org/10.1007/0-306-47513-8_3
25. Maslow A. Motivation and Personality. New York, NY: Harper; 1954.
26. Rettig KD, Leichnetritt RD. A general theory for perceptual indicators of family life quality. Soc Indic Res 1999;47:307-42.
27. Higgs P, Hyde M, Wiggins RD, Blane DB. Research quality of life in early old age: the importance of the sociological dimension. Soc Policy Adm 2003;37:239-52. http://dx.doi.org/10.1111/ 1467-9515.00336
28. Netten A, Burge P, Malley J, Potoglou D, Towers AM, Brazier J, et al. Outcomes of social care for adults: developing a preference weighted measure. Health Technol Assess 2012;16(16).
29. Dolan P, Peasgood T, White M. Do we know what makes us happy? A review of the economic literature on the factors associated with subjective wellbeing. J Econ Psychol 2008;29:94-122.
30. Bentham J. Deontology. Oxford: Clarendon Press; 1983.
31. Kahneman D, Wakker P, Sarin R. Back to Bentham? Explorations of experienced utility. Q J Econ 1997;112:374-406. http://dx.doi.org/10.1162/003355397555235
32. Diener E, Lucas RE. Subjective emotional well-being. In Lewis M, Haviland JM, editors. Handbook of Emotions. 2nd edn. New York, NY: Guilford; 2000. pp. 325-37.
33. Diener E, Emmons RA, Larson RJ, Griffin S. The satisfaction with life scale. J Pers Assess 1985;49:71-5. http://dx.doi.org/10.1207/s15327752jpa4901_13
34. Fisher I. Is 'utility' the most suitable term for the concept it is used to denote? Am Econ Rev 1918;8:335-7.
35. Dolan P, Kahneman D. Interpretations of utility and their implications for the valuation of health. Econ J 2008;118:215-34. http://dx.doi.org/10.1111/j.1468-0297.2007.02110.x
36. Sen AK. Commodities and Capabilities. Oxford: Oxford University Press; 1985.
37. Sen AK. Capability and wellbeing. In Nussbaum MC, Sen AK, editors. The Quality of Life. New York, NY: Oxford Clarendon Press; 1993. pp. 30-53.
38. Nussbaum MC. Capabilities as fundamental entitlements: Sen and social justice. Fem Econ 2003;9:33-59. http://dx.doi.org/10.1080/1354570022000077926
39. Grewal I, Lewis J, Flynn TN, Brown J, Coast J. Developing attributes for a generic quality of life measure for older people: preferences or capabilities? Soc Sci Med 2006;62:1891-901. http://dx.doi.org/10.1016/j.socscimed.2005.08.023
40. Al-Janabi H, Flynn T, Coast J. Development of a self-report measure of capability well-being for adults: the ICECAP-A. Qual Life Res 2012;21:167-76.
41. Barry MM. Wellbeing and Life Satisfaction as Components of Quality of Life in Mental Disorders. Chichester: John Wiley and Sons; 2006.
42. Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychol Med 1998;28:1221-30. http://dx.doi.org/10.1017/ S0033291798007338
43. Bowling A. Measuring Health: A Review of Quality of Life and Measurement Scales. Milton Keynes: Oxford University Press; 2002.
44. World Health Organization (WHO). Constitution of the World Health Organization. Geneva: WHO; 1948.
45. Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113-27. http://dx.doi.org/10.1046/ j.1524-4733.1999.02210.x
46. Katschnig H. Quality of life in mental disorders: challenges for research and clinical practice. World Psychiatry 2006;5:139-45.
47. Chisholm D, Healey A, Knapp M. QALYs and mental health care. Soc Psychiatry Epidemiol 1997;32:68-75. http://dx.doi.org/10.1007/BF00788923
48. van de Willige G, Wiersma D, Nienhuis FJ, Jenner JA. Changes in quality of life in chronic psychiatric patients: a comparison between EuroQol (EQ-5D) and WHOQoL. Qual Life Res 2005;14:441-51. http://dx.doi.org/10.1007/s11136-004-0689-y
49. Moock JK. Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. Qual Life Res 2008;17:485-95. http://dx.doi.org/10.1007/s11136-008-9317-6
50. Lamers LM, Bouwmans CA, van Straten A, Donker MC, Hakkaart L. Comparison of EQ-5D and SF-6D utilities in mental health. Health Econ 2006;15:1229-36. http://dx.doi.org/10.1002/ hec.1125
51. Brazier J, Rowen D, Mavranezouli I, Tsuchiya A, Young T, Yang Y. Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome). Health Technol Assess 2012;16(32).
52. Mavranezouli I, Brazier J, Young T, Barkham M. Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from a measure of common mental health problems. Qual Life Res 2011;20:321-33. http://dx.doi.org/10.1007/s11136-010-9768-4
53. Fitzpatrick R, Davey C, Buxton M, Jones D. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998;6(29).
54. Brazier J, Deverill M. A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. Health Econ 1999;8:41-51. http://dx.doi.org/10.1002/(SICI) 1099-1050(199902)8:1%3C41::AID-HEC395%3E3.3.CO;2-R
55. Streiner DL, Norman GR. Health Measurement Scales: a Practical Guide to Their Development and Use. Oxford: Oxford University Press; 1989.
56. Bowling A. Measuring Health. A Review of Quality of Life Measurement Scales. Buckingham: Open University Press; 1997.
57. American Psychological Association. Committee on Psychological Tests. Technical Recommendations for Psychological Tests and Diagnostic Techniques. Washington, DC: American Psychological Association; 1954.
58. US Department of Health and Human Services Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Resesarch (CBER), Center for Devices and Radiological Health (CDRH). Guidance for Industry: Patient-reported Outcome Measures: Use in Medical Product Development to Support Labelling Claims. FDA; 2009. URL: www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ ucm193282.pdf (accessed 2 January 2014).
59. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-25. http://dx.doi.org/10.1097/00005650-199210000-00004
60. Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures such as EQ-5D and SF-6D, in schizophrenia? A systematic review. Value Health 2011;14:907-20.
61. Papaioannou D, Brazier JE, Parry G. How to measure quality of life for cost effectiveness analyses in personality disorders? A systematic review. J Personal Disord 2013;27:383-401. http://dx.doi.org/10.1521/pedi_2013_27_075
62. Peasgood T, Brazier J, Papaioannou D. A Systematic Review of the Validity and Responsiveness of the EQ-5D and the SF-6D for Depression and Anxiety. Health Economics and Decision Science discussion paper 12/15. Sheffield: Health Economics and Decision Science, University of Sheffield; 2012.
63. Fitzsimmons D, Gilbert J, Howse F, Young T, Arraras J, Brident A, et al. A systematic review of the use and validation of health-related quality of life instruments in older cancer patients. Eur J Cancer Care 2004;45:19-32. http://dx.doi.org/10.1016/j.ejca.2008.07.036
64. Walters SJ. Quality of Life Outcomes in Clinical Trials and Health-care Evaluation: A Practical Guide to Analysis and Interpretation. Chichester: Wiley-Blackwell; 2009.
65. Cohen J. Statistical Power Analysis for the Behavioural Sciences. 2nd edn. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
66. Lenert LA, Rupnow MF, Elnitsky C. Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia. Health Qual Life Outcomes 2005;3:57.
67. Bebbington PE, Angermeyer M, Azorin JM, Marwaha S, Marteau F, Tourni M. Side-effects of antipsychotic medication and health-related quality of life in schizophrenia. Acta Psychiatr Scand 2009;119:22-8. http://dx.doi.org/10.1111/j.1600-0447.2008.01310.x
68. McCrone P, Patel A, Knapp M, Schene A, Koeter M, Amaddeo F, et al. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia. J Ment Health Policy Econ 2009;12:27-31.
69. Revicki D, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM. Olanzapine versus haloperidal in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized controlled trial. Qual Life Res 1999;8:417-26.
70. Strakowski SM, Johnson JL, Delbello MP, Hamer RM, Green AI, Tohen M, et al. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophr Res 2005;78:161-9. http://dx.doi.org/10.1016/j.schres.2005.04.017
71. Tunis SL, Croghan TW, Heilman DK, Johnston BM, Obenchain RL. Reliability, validity and application of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) in schizophrenic patients treated with olanzapine verus haloperidal. Med Care 1999;37:678-91.
72. Nasrallah HA, Duchesne I, Mehnert A, Janagap C, Eerdekens M, Nasrallah HA, et al. Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. J Clin Psychiatry 2004;65:531-6. [Erratum appears in J Clin Psychiatry 2004;65:1150]. http://dx.doi.org/10.4088/JCP.v65n0412
73. Russo J, Trujillo CA, Wingerson D, Decker K, Ries R, Wetzler H, et al. The MOS 36-Item Short Form Health Survey: reliability, validity and preliminary findings in schizophrenia outpatients. Med Care 1998;36:752-6. http://dx.doi.org/10.1097/00005650-199805000-00015
74. Kebede D, Alem A, Shibre T, Alemayehu N, Negussie D, Beyero T, et al. Health related quality of life (SF-36) survey in Butajira, rural Ethopia: normative data and evaluation of reliability and validity. Ethiop Med J 2004;42:289-97.
75. Kebede D, Alem A, Shibre T, Negash A, Deyassa N, Beyero T, et al. Short-term symptomatic and functional outcomes of schizophrenia in Butajira. Ethiop Med J 2005;78:171-85. http://dx.doi. org/10.1016/j.schres.2005.05.028
76. Norholm V, Bech P. Quality of life assessment in schizophrenia: applicability of the Lehman Quality of Life Questionnaire (TL-30). Nord J Psychiatry 2007;61:438-42. http://dx.doi.org/ 10.1080/08039480701773154
77. Folsom DP, Depp C, Palmer BW, Mausbach BT, Golshan S, Fellows I, et al. Physical and mental health-related quality of life among older people with schizophrenia. Schizophr Res 2009;108:207-13. http://dx.doi.org/10.1016/j.schres.2008.12.008
78. Sciolla A, Patterson TL, Wetherell JL, McAdams LA, Jeste DY. Functioning and well-being of middle aged and older patients with schizophrenia: measurement with the 36-item short form (SF-36) health survey. Am J Geriatr Psychol 2003;11:629-37. http://dx.doi.org/10.1176/appi. ajgp.11.6.629
79. Pukrop R, Schlaak V, Moller-Leimkuhler AM, Albus M, Czernik A, Klosterkotter J, et al. Reliability and validity of quality of life assessed by the Short-Form SF-36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression. Psychol Res 2003;119:63-79.
80. Law CW, Chen EY, Cheung EF, Chan RC, Wong JG, Lam CL, et al. Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Qual Life Res 2005;14:1803-11. http://dx.doi.org/10.1007/s11136-005-3236-6
81. Meijer CJ, Schene AH, Koeter MW. Quality of life in schizophrenia measured by the MOS SF-36 and the Lancashire Quality of Life Profile: a comparison. Acta Psychiatr Scand 2002;105:293-300. http://dx.doi.org/10.1034/j.1600-0447.2002.1198.x
82. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 2000;177:42-6. http://dx.doi. org/10.1192/bjp.177.1.42
83. Milliken HI, Whitehorn D, Rui Q, Ronson K. SF-36: a measure of recovery in the first six months of treatment for schizophrenia. Schizophr Bull 2007;33:597-8.
84. Auquier P, Simeoni MC, Sapin C, Reine G, Aghababian V, Cramer J, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res 2003;63:137-49. http://dx.doi.org/10.1016/S0920-9964(02)00355-9
85. Bobes J, Gonzalez MP, Saiz PA. The SF-36 versus the WHOQOL-100 and-26 in schizophrenic private out-patients. Qual Life Res 1997;6:126.
86. Prieto L, Sacristan JA, Hormaechea JA, Casado A, Badia X, Gomez JC, et al. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin 2004;20:827-35. http://dx.doi.org/10.1185/030079904125003674
87. Badia X, Casado A, Sacristan JA, Gomez JC, Gregor KJ. Antipsychotic treatment and changes in health related quality of life in patients with schizophrenia using EQ-5D. International Society for Pharmacoeconomics and Outcomes Research, Second Annual European Meeting, Edinburgh, November 1999.
88. Reine G, Simeoni MC, Auquier P, Loundou A, Aghababian V, Lancon C. Assessing health-related quality of life in patients suffering with schizophrenia: a comparison of instruments. Eur Psychiatry 2005;20:510-19. http://dx.doi.org/10.1016/j.eurpsy.2005.05.009
89. Barton GR, Hodgekins J, Mugford M, Jones PB, Croudace T, Fowler D. Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D. Br J Psychiatry 2009;195:170-7. http://dx.doi.org/10.1192/bjp.bp.108.057380
90. Konig HH, Roick C, Angermeyer M. Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenia, schizotypal or delusional disorders. Eur Psychiatry 2007;22:177-87. http://dx.doi.org/10.1016/j.eurpsy.2006.08.004
91. Konig HH, Gunther OH, Angermeyer MC, Roick C. Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method. Pharmacoeconomics 2009;27:405-19. http://dx.doi.org/10.2165/00019053-200927050-00005
92. Scalone L, Pirfo E, Mencacci C, Ferranini L, Berto P, Sturkenboom MC, et al. Relationship between clinical outcomes and patients' reported outcomes in schizophrenia: the contribution of the EQ-5D. Value Health 2008;11:A592.
93. Dunayevich E, Ascher-Svanum H, Zhao F, Jacobson JG, Phillips GA, Dellva MA, et al. Longer time to antipsychotic treatment discontinuation for any cause is assocated with better functional outcomes for patients with schizophrenia, schizophreniform disorder or schizoaffective disorder. J Clin Psychiatry 2007;68:1163-71.
94. Phillips GA, Van Brunt DL, Roychowdhury SM, Xu W, Naber D. The relationship between quality of life and clinical efficacy from a randomized trial comparing olanzapine and ziprasidone. J Clin Psychiatry 2006;67:1397-403. http://dx.doi.org/10.4088/JCP.v67n0910
95. Pyne JM, Sullivan G, Kaplan R, Williams DK. Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia. Med Care 2003;41:208-17. http://dx.doi.org/10.1097/01.MLR.0000044900.72470.D4
96. Sanderson K, Andrews G, Alem A. Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv 2002;53:80-6. http://dx.doi.org/10.1176/appi.ps.53.1.80
97. Albert U, Rosso G, Maina G, Bogetto F. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord 2008;105:297-303. http://dx.doi.org/10.1016/j.jad.2007.05.020
98. Arbuckle R, Frye MA, Brecher M, Paulsson B, Rajagopalan K, Palmer S, et al. The psychometric validation of the Sheehan Disability Scale (SDS) in patients with bipolar disorder. Psychiatry Res 2009;165:163-74. http://dx.doi.org/10.1016/j.psychres.2007.11.018
99. Hayhurst H, Palmer S, Abbott R, Johnston T, Scott J. Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures. Qual Life Res 2006;15:1271-80. http://dx.doi.org/10.1007/s11136-006-0059-z
100. Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, et al. The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands. Acta Psychiatr Scand 2004;110:383-92. http://dx.doi.org/10.1111/j.1600-0447.2004.00403.x
101. Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001;42:190-5. http://dx.doi.org/10.1053/ comp.2001.23143
102. Arnold LM, Witzeman KA, Swank ML, McElroy SL, Keck PE Jr, Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. J Affect Disord 2000;57:235-9. http://dx.doi.org/10.1016/S0165-0327 (99)00042-7
103. Bauer MS, Altshuler L, Evans DR, Beresford TP, Williford WO, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005;85:301-15. http://dx.doi.org/10.1016/ j.jad.2004.11.009
104. Cuijpers P, Smits N, Donker T, ten Have M, de Graaf R. Screening for mood and anxiety disorders with the five-item, the three-item and the two-item Mental Health Inventory. Psychiatry Res 2009;168:250-5. http://dx.doi.org/10.1016/j.psychres.2008.05.012
105. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 2006;67:215-21. http://dx.doi.org/10.4088/JCP.v67n0207
106. Depp CA, Mausbach BT, Eyler LT, Palmer BW, Cain AE, Lebowitz BD, et al. Performance-based and subjective measures of functioning in middle-aged and older adults with bipolar disorder. J Nerv Ment Dis 2009;197:471-5. http://dx.doi.org/10.1097/NMD.0b013e3181ab5c9b
107. Gutierrez-Rojas L, Gurpegui M, yuso-Mateos JL, Gutierrez-Ariza JA, Ruiz-Veguilla M, Jurado D, et al. Quality of life in bipolar patients: a comparison with a general population sample. Bipolar Disord 2008;10:625-34. http://dx.doi.org/10.1111/j.1399-5618.2008.00604.x
108. Kebede D, Alem A, Shibire T, Deyassa A, Negash A, Beyero T, et al. Symptomatic and functional outcome of bipolar disorder in Butarija, Ethiopia. J Affect Disord 2006;90:239-49.
109. Leidy NK, Palmer C, Murray M, Robb J, Revicki D. Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measures. J Affect Disord 1998;48:207-14.
110. Maina G, Albert U, Bellodi L, Colombo C, Faravelli C, Monteleone P, et al. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry 2007;68:207-12. http://dx.doi.org/10.4088/JCP.v68n0205
111. Namjoshi M, Rajamannar G, Jacobs T, Sanger TM, Risser R, Tohen MF, et al. Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. J Affect Disord 2002;69:109-18. http://dx.doi.org/10.1016/ S0165-0327(01)00310-X
112. Shi L, Namjoshi MA, Swindle R, Yu X, Risser R, Baker RW, et al. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. Clin Ther 2004;26:125-34. [Erratum appears in Clin Ther 2004;26:1934.]
113. Shi L, Namjoshi MA, Zhang F, Gandhi G, Edgell ET, Tohen M, et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002:17:227-37. http://dx.doi.org/10.1097/00004850-200209000-00003
114. Sierra P, Livianos L, Rojo L. Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables. Bipolar Disord 2005:7:159-65. http://dx.doi.org/10.1111/ j.1399-5618.2005.00186.x
115. Simon GE, Bauer MS, Ludman EJ, Operskalski BH, Unutzer J. Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression. J Clin Psychiatry 2007;68:1237-45. http://dx.doi.org/10.4088/JCP.v68n0811
116. Yatham LN, Lecrubier Y, Fieve RR, Davis KH, Harris SD, Krishnan AA. Quality of life in patients with bipolar I depression: data from 920 patients. Bipolar Disord 2004;6:379-85. http://dx.doi. org/10.1111/j.1399-5618.2004.00134.x
117. Zhang H, Wisniewski SR, Bauer MS, Sachs GS, Thase ME. Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) investigators. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants. Compr Psychiatry 2006;47:161-8.
118. Jarema M, Konieczynska Z. Quality of life in schizophrenia: impact of psycopathology, patients' gender and antipsychotic treatment. Int J Psychiatry Clin Pract 2001;5:19-26.
119. Narud K, Mykletun A, Dahl AA. Quality of life in patients with personality disorders seen at an ordinary psychiatric outpatient clinic. BMC Psychiatry 2005;5:10.
120. Soeteman D, Verheul R, Busschbach J. The burden of disease in personality disorders: diagnosis-specific quality of life. J Personal Disord 2008;22:259-68. http://dx.doi.org/10.1521/ pedi.2008.22.3.259
121. Hueston WJ, Mainous AG III, Schilling R. Patients with personality disorders: functional status, health care utilization, and satisfaction with care. J Fam Pract 1996;42:54-60.
122. Jackson HJ, Burgess PM. Personality disorders in the community: a report from the Australian National Survey of Mental Health and Wellbeing. Soc Psychiatry Psychiatr Epidemiol 2000;35:531-8. http://dx.doi.org/10.1007/s001270050276
123. Jackson HJ, Burgess PM. Personality disorders in the community: results from the Australian Survey of Mental Health and Wellbeing Part II. Relationships between personality disorder, Axis I mental disorders and physical conditions with disability and health consultations. Soc Psychiatry Psychiatr Epidemiol 2002;37:251-60. http://dx.doi.org/10.1007/s001270200017
124. Bartak A, Andrea H, Spreeuwenberg MD, Ziegler UM, Dekker J, Rossum BV, et al. Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorders. Psychother Psychosom 2011;80:28-38. http://dx.doi.org/10.1159/ 000321999
125. Bartak A, Andrea H, Spreeuwenberg MD, Thunnissen M, Ziegler UM, Dekker J, et al. Patients with cluster A personality disorders in psychotherapy: an effectiveness study. Psychother Psychosom 2011;80:88-99.
126. Bartak A, Spreeuwenberg MD, Andrea H, Holleman L, Rijnierse P, Rossum BV, et al. Effectiveness of different modalities of psychotherapeutic treatment for patients with cluster C personality disorders: results of a large prospective multicentre study. Psychother Psychosom 2010;79:20-30. http://dx.doi.org/10.1159/000254902
127. Soeteman DI, Timman R, Trijsburg RW, Verheul R, Busschbach JJ. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatr Serv 2005;56:1153-5. http://dx.doi.org/10.1176/appi.ps.56.9.1153
128. van Asselt AD, Dirksen CD, Arntz A, Giesen-Bloo JH, Severens JL. The EQ-5D: A useful quality of life measure in borderline personality disorder? Eur Psychiatry 2009;24:79-85. http://dx.doi.org/ 10.1016/j.eurpsy.2008.11.001
129. Aydemir R, Ergun H, Soygur H, Kesebir S, Tulunay C. [Quality of life in major depressive disorder: a cross-sectional study.] Turk Psikiyatri Derg 2009;20:205-12.
130. Bosmans JE, Hermens MLM, de Bruijne MC, van Hout HPJ, Terluin B, Bouter LM, et al. Cost-effectiveness of usual general practitioner care with or without antidepressant medication for patients with minor or mild-major depression. J Affect Disord 2008;111:106-12. http://dx.doi.org/10.1016/j.jad.2008.02.002
131. Caruso R, Rossi A, Barraco A, Quail D, Grassi L. The Factors Influencing Depression Endpoints Research (FINDER) study: final results of Italian patients with depression. Ann Gen Psychiatry 2010;9:33.
132. Ergun H, Aydemir O, Kesebir S, Soygur H, Tulunay FC. SF-36 and EQ-5D quality of life instruments in major depressive disorder patients: comparisons of two different treatment options. Value Health 2007;10:A303. http://dx.doi.org/10.1016/S1098-3015(10)65099-1
133. Fernandez JL, Montgomery S, Francois C. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder. Pharmacoeconomics 2005;23:155-67. http://dx.doi.org/10.2165/00019053-200523020-00007
134. Gunther OH, Roick C, Angermeyer MC, Konig HH. The responsiveness of EQ-5D utility scores in patients with depression: a comparison with instruments measuring quality of life, psychopathology and social functioning. J Affect Disord 2008;105:87-91.
135. Konig HH, Born A, Heider D, Matschinger H, Heinrich S, Riedel-Heller SG, et al. Cost-effectiveness of a primary care model for anxiety disorders. Br J Psychiatry 2009;195:308-17. http://dx.doi.org/ 10.1192/bjp.bp.108.058032
136. Konig HH, Born A, Gunther O, Matschinger H, Heinrich S, Riedel-Heller SG, et al. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health Qual Life Outcomes 2010;8:47. http://dx.doi.org/10.1186/1477-7525-8-47
137. Mann R, Gilbody S, Richards D. Putting the 'Q' in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures. Soc Psychiatry Psychiatr Epidemiol 2009;44:569-78. http://dx.doi.org/10.1007/s00127-008-0463-5
138. Mychaskiw M, Hoffman D, Dodge W. EQ-5D index scores by remission status in patients with generalised anxiety disorder. Int J Neuropsychopharmacol 2008;11:279.
139. Petrou S, Morrell J, Spiby H. Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes 2009;7:40. http://dx.doi.org/ 10.1186/1477-7525-7-40
140. Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess 2005;9(16).
141. Pyne JM, Fortney JC, Tripathi SP, Maciejewski ML, Edlund MJ, Williams DK. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Arch Gen Psychiatry 2010;67:812-21. http://dx.doi.org/10.1001/archgenpsychiatry.2010.82
142. Reed C, Monz BU, Perahia DG, Gandhi P, Bauer M, Dantchev N, et al. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER. J Affect Disord 2009;113:296-302. http://dx.doi.org/10.1016/j.jad.2008.05.021
143. Revicki DA, Brandenburg N, Matza L, Hornbrook MC, Feeny D. Health-related quality of life and utilities in primary-care patients with generalised anxiety disorder. Qual Life Res 2008;17:1285-94.
144. Saarni SI, Suvisaari J, Sintonen H, Pirkola S, Koskinen S, Aromaa A, et al. Impact of psychiatric disorders on health-related quality of life: general population survey. Br J Psychiatry 2007;190:326-32. http://dx.doi.org/10.1192/bjp.bp.106.025106
145. Sapin C, Fantino B, Nowicki ML, Kind P. Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes 2004;2:20.
146. Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Martensson B, et al. Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health 2007;10:153-60. http://dx.doi.org/10.1111/j.1524-4733.2006.00162.x
147. Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Pyne JM, et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care 2005;43:1164-70. http://dx.doi.org/10.1097/01.mlr.0000185750.18119.fd
148. Supina AL, Johnson JA, Patten SB, Williams JVA, Maxwell CJ. The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety. Qual Life Res 2007;16:749-54. http://dx.doi.org/10.1007/s11136-006-9159-z
149. Zivin K, McCarthy JF, McCammon RJ, Valenstein M, Post EP, Welsh DE, et al. Health-related quality of life and utilities among patients with depression in the Department of Veterans Affairs. Psychiatr Serv 2008;59:1331-4. http://dx.doi.org/10.1176/appi.ps.59.11.1331
150. Kendrick T, Peveler R, Longworth L, Baldwin D, Moore M, Chatwin J, et al. Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and Iofepramine. Br J Psychiatry 2006;188:337-45.
151. Morrell CJ, Slade P, Warner R, Paley G, Dixon S, Walters SJ, et al. Clinical effectivneness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ 2009;338:a3045.
152. Parry G, Barkham M, Brazier J, Dent-Brown K, Hardy G, Kendrick T, et al. An evaluation of a new service model: Improving Access to Psychological Therapies demonstration sites 2006-2009. Final report. NIHR Service Delivery and Organisation Programme; 2011.
153. Tyrer P, Tom B, Byford S, Schmidt U, Jones V, Davidson K, et al. Differential effects of manual assisted cognitive behavior therapy on the treatment of recurrent deliberate self-harm and personality disturbance: the POPMACT study. J Personal Disord 2004;18:102-16. http://dx.doi. org/10.1521/pedi.18.1.102.32770
154. Gray R, Leese M, Bindman J, Becker T, Burti L, David A. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br J Psychiatry 2006;189:508-14. http://dx.doi.org/10.1192/bjp.bp.105.019489
155. Crawford M, Killaspy H, Kalaitzaki E, Barrett B, Byford S. The MATISSE study: a randomised trial of group art therapy for people with schizophrenia. BMC Psychiatry 2010;10:65. http://dx.doi.org/ 10.1186/1471-244X-10-65
156. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70. http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x
157. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002;52:69-77.
158. Lisspers J, Nygren A, Soderman E. The Hospital Anxiety and Depression Scale (HAD): some psychometric data for a Swedish sample. Acta Psychiatr Scand 1997;96:281-6. http://dx.doi.org/ 10.1111/j.1600-0447.1997.tb10164.x
159. Suarez-Mendoza AA, Cardiel MH, Caballero-Uribe CV, Ortega-Soto HA, Marquez-Marin M. Measurement of depression in Mexican patients with rheumatoid arthritis: validity of the Beck Depression Inventory. Arthritis Care Res 1997;10:194-9. http://dx.doi.org/10.1002/ art.1790100307
160. Fossa SD, Dahl AA. Short Form 46 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer. J Psychosom Res 2002;52:79-87.
161. Barkham M, Evans C, Margison F, McGrath G, Mellor-Clark J, Connell J, et al. The rationale for developing and implementing core batteries for routine use in service settings and psychotherapy outcome research. J Ment Health 1998;7:35-47.
162. Barkham M, Margison F, Leach C, Lucock M, Mellor-Clark J, Evans C, et al. Service profiling and outcome benchmarking using the CORE-OM: towards practice based evidence in the psychological therapies. J Consult Clin Psychol 2001;69:184-96. http://dx.doi.org/10.1037// 0022-006X.69.2.184
163. Barkham M, Gilbert N, Connell J, Marshall C, Twigg E. Suitability and utility of the CORE-OM and CORE-A for assessing severity of presenting problems in psychological therapy services based in primary and secondary care settings. Br J Psychiatry 2005;186:239-46. http://dx.doi.org/10.1192/ bjp.186.3.239
164. Evans C, Connell J, Barkham M, Margison F, McGrath G, Mellor-Clark J, et al. Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM. Br J Psychiatry 2002;180:51-60. http://dx.doi.org/10.1192/bjp.180.1.51
165. Evans C, Mellor-Clark J, Margison K, Barkham M, Audin K, Connell J, et al. CORE: Clinical Outcomes in Routine Evaluation. J Ment Health 2000;9:247-55. http://dx.doi.org/10.1080/ 713680250
166. Barkham M, Mullin T, Leach C, Stiles WB, Lucock M. Stability of the CORE-OM and the BDI-I prior to therapy: evidence from routine practice. Psychol Psychother 2007;80:269-78. http://dx.doi.org/ 10.1348/147608306X148048
167. Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK valuations of PHQ-9 and CORE-OM. Br J Gen Pract 2007;57:650-2.
168. Ventura J, Lukoff D, Neuchterlein K, Liberman R, Green M, Shaner A, et al. Brief Psychiatric Rating Scale (BPRS) Expanded Version (4.0) scales, anchor points and administration manual. Int J Psychiatry Clin Pract 1993;3:227-43.
169. Mortimer M. Symptom rating scales and outcome in schizophrenia. Br J Psychiatry 2007;191:S7-14. http://dx.doi.org/10.1192/bjp.191.50.s7
170. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-76. http://dx.doi.org/10.1093/schbul/13.2.261
171. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988;23:99-110. http://dx.doi.org/10.1016/0165-1781 (88)90038-8
172. Byford S, Knapp M, Greenshields J, Ukoumunne OC, Jones V, Thompson S, et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a rational decision making approach. Psychol Med 2003;33:977-86.
173. Cleveland W. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36. http://dx.doi.org/10.2307/2286407
174. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. Br J Psychiatry 2005;187:366-71. http://dx.doi.org/10.1192/ bjp.187.4.366
175. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. What does the PANSS mean? Schizophr Res 2005;79:231-8. http://dx.doi.org/10.1016/j.schres.2005.04.008
176. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res 2003;12:349-62.
177. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;10:1727-36. http://dx.doi.org/10.1007/s11136-011-9903-x
178. Brazier J, Yang Y, Tsuchiya A, Rowen D. A review of studies mapping (or cross walking) non-preference based measures. Eur J Health Econ 2010;11:215-25. http://dx.doi.org/10.1007/ s10198-009-0168-z
179. King M, Nazroo J, Weich S, McKenzie K, Bhui K, Karlsen S. Psychotic symptoms in the general population of England: a comparison of ethnic groups (the EMPIRIC study). Soc Psychiatry Psychiatr Epidemiol 2005;40:375-81. http://dx.doi.org/10.1007/s00127-005-0900-7
180. Longworth L, Rowen D. The Use of Mapping Methods to Estimate Health State Utility Values. NICE Decision Support Unit (DSU) Technical Support Document 10. Sheffield: DSU, School of Health and Related Research, University of Sheffield; 2011.
181. Gray AM, Rivero-Arias O, Clark PM. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making 2006;26:18-29. http://dx.doi.org/ 10.1177/0272989X05284108
182. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-13. http://dx.doi.org/10.1046/j.1525-1497.2001.016009606.x
183. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self report version of PRIME-MD: the PHQ primary care study. Arch Intern Med 1999;166:1092-7.
184. Martin A, Rief W, Klaiberg A, Braehler E. Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry 2006;28:71-7. http://dx.doi.org/ 10.1016/j.genhosppsych.2005.07.003
185. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7. http://dx.doi.org/10.1001/ archinte.166.10.1092
186. Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med 2006;11:184. http://dx.doi.org/10.1136/ebm.11.6.184
187. Goldberg DP, Williams P. A User's Guide to the General Health Questionnaire. Windsor: Nelson; 1988.
188. Hardy G, Shapiro DA, Haynes CE, Rick JE. Validation of the General Health Questionnaire-12: Using a sample of employees from England's health care services. Psychol Assess 1999;11:159-65. http://dx.doi.org/10.1037//1040-3590.11.2.159
189. Tyrer P, Thompson S, Schmidt U, Jones V, Knapp M, Davidson K, et al. Randomised controlled trial of brief cognitive behavour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med 2003;33:977-86.
190. Lewis G, Pelosi AJ, Araya R, Dunn G. Measuring psychiatric disorder in the community: a standardised assessment for use by lay interviewers. Psychol Med 1992;22:465-86.
191. Mortimer D, Segal L, Hawthorne G, Harris A. Item-based versus subscale-based mapping form the SF-36 to a preference-based quality of life measure. Value Health 2007;10:398-470.
192. Versteegh MM, Rowen D, Brazier J, Stolk EA. Mapping onto EQ-5D for patients in poor health. Health Qual Life Outcomes 2010;8:141.
193. Lin F, Longworth L, Pickard S. Evaluation of content on EQ-5D as compared to disease-specific utility measures. Qual Life Res 2012;22:853-74. http://dx.doi.org/10.1007/s11136-012-0207-6
194. Serrano-Aguilar P, Ramallo-Farina Y, Trujillo-Martin Mdel M, Munoz-Navarro SR, Perestelo-Perez L, de las Cuevas-Castresana C. The relationship among mental health status (GHQ-12), health related quality of life (EQ-5D) and health-state utilities in a general population. Epidemiol Psichiatr Soc 2009;18:229-39.
195. Jacobs R. Investigating Patient Outcome Measures in Mental Health. Research report for the Office of Health Economics Commission on NHS Productivity. York: Centre for Health Economics; 2007.
196. Barnett-Paige E, Thomas J. Methods for the synthesis of qualitative research: a critical review. BMC Med Res Methodol 2009;9:59. http://dx.doi.org/10.1186/1471-2288-9-59
197. Paterson DL, Thomas SE. Meta-Study of Qualitative Health Research: A Practical Guide to Meta-Analysis and Meta-Synthesis. Thousand Oaks, CA: Sage; 2001.
198. Ritchie J, Spencer L. Qualitative Data Analysis for Applied Policy Research. London: Routledge; 1994.
199. Connell J, Brazier JE, O'Cathain A, Lloyd-Jones M, Paisley S. Quality of life of people with mental health problems: a synthesis of qualitative research. Health Qual Life Outcomes 2012;10:138. http://dx.doi.org/10.1186/1477-7525-10-138
200. Sandelowski M, Docherty S, Emden C. Qualitative meta-synthesis: issues and techniques. Res Nurs Health 1997;20:365-71.
201. Hagerty BMK, Lynch-Sauer J, Patusky KL, Bouwsema M, Collier P. Sense of belonging: a vital mental health concept. Arch Psychiatr Nurs 1992;6:172-217. http://dx.doi.org/10.1016/ 0883-9417(92)90028-H
202. Wilcock AA. Reflections on doing, being and becoming. Can J Occup Ther 1998;65(5):279-85.
203. de Leval N. The Three Time Dimensions Synoptic Scale (3TSS) for Depressive Population. Quality of Life Newsletter 2001;26:15-16.
204. Diener E. Guidelines for National Indicators of Subjective Well-Being and Ill-Being. Appl Res Qual Life 2006;1:151-7. http://dx.doi.org/10.1007/s11482-006-9007-x
205. Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry 2002;36:733-42. http://dx.doi.org/10.1046/j.1440-1614.2002.01086.x
206. Corring DJ. 'Being Normal': Quality of Life Domains for Persons with a Mental Illness. Dissertation Abstracts International Section B: Sciences and Engineering 2006;67.
207. Michalak EE, Yatham LN, Maxwell V, Hale S, Lam RW. The impact of bipolar disorder upon work functioning: a qualitative analysis. Bipolar Disord 2007;9:126-43. http://dx.doi.org/10.1111/ j.1399-5618.2007.00436.x
208. Cook S, Chambers E. What helps and hinders people with psychotic conditions doing what they want in their daily lives. Br J Occup Ther 2009;72:238-48.
209. Corring DJ, Cook JV. Use of qualitative methods to explore the quality-of-life construct from a consumer perspective. Psychiatr Serv 2007;58:240-4. http://dx.doi.org/10.1176/appi.ps.58.2.240
210. Fisher MA, Mitchell GJ. Patients' views of quality of life: transforming the knowledge base of nursing. Clin Nurse Spec 1998;12:99-105.
211. Gee L, Pearce E, Jackson M. Quality of life in schizophrenia: a grounded theory approach. Health Qual Life Outcomes 2003;1:31.
212. Gould A, DeSouza S, Rebeiro-Gruhl KL. And then I lost that life: a shared narrative of four young men with schizophrenia. Br J Occup Ther 2005;68:467-73.
213. Hamer HP, McCallin AM, Garrett N. Searching for self: the layers and labels of panic disorder: a New Zealand study. Nurs Health Sci 2009;11:51-7. http://dx.doi.org/10.1111/j.1442-2018.2009.00430.x
214. Hedberg L, Skarsater I. The importance of health for persons with psychiatric disabilities. J Psychiatr Ment Health Nurs 2009;16:455-61. http://dx.doi.org/10.1111/j.1365-2850. 2009.01400.x
215. Laliberte-Rudman D, Yu B, Scott E, Pajouhandeh P. Exploration of the perspectives of persons with schizophrenia regarding quality of life. Am J Occup Ther 2000;54:137-47. http://dx.doi.org/ 10.5014/ajot.54.2.137
216. Lim L, Nathan P, O'Brien-Malone A, Williams S. A qualitative approach to identifying psychosocial issues faced by bipolar patients. J Nerv Ment Disord 2004;192:810-17. http://dx.doi.org/10.1097/ 01.nmd.0000146734.39501.57
217. Mayers CA. Quality of life: priorities for people with enduring mental health problems. Br J Occup Ther 2000;63:591-6.
218. Michalak EE, Yatham LN, Kolesar S, Lam RW. Bipolar disorder and quality of life: a patient-centered perspective. Qual Life Res 2006;15:25-37. http://dx.doi.org/10.1007/ s11136-005-0376-7
219. Rusner M, Carlsson G, Brunt D, Nystrom M. A dependence that empowers-the meaning of the conditions that enable a good life with bipolar disorder. Int J Qual Stud Health Well-being 2010;5(1). http://dx.doi.org/10.3402/qhw.v5i1.4653
220. Vallenga BA, Christenson J. Persistent and severely mentally ill clients' perceptions of their mental health. Issues Ment Health Nurs 1994;15:359-71.
221. Goffman E. Stigma: Notes on the Management of Spoiled Identity. London: Penguin Books; 1963.
222. Erikson EH. Childhood and Society. New York, NY: WW Norton; 1963.
223. Baumeister R, Leary M. The need to belong: desire for interpersonal attachments as a fundamental human motivation. Psychol Bull 1995;117:497-529. http://dx.doi.org/10.1037// 0033-2909.117.3.497
224. Anant SS. The need to belong. Can Ment Health 1966;14:21.
225. Hansson L. Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand 2006;113(Suppl. 429):46-50. http://dx.doi.org/10.1111/j.1600-0447.2005.00717.x
226. El-Badri S, Mellsop G. Stigma and quality of life as experienced by people with mental illness. Australas Psychiatry 2007;15:195-200. http://dx.doi.org/10.1080/10398560701320089
227. Newsom JT, Rook KS, Nishishiba M, Sorkin DH, Mahan TL. Understanding the relative importance of positive and negative social exchanges: examining specific domains and appraisals. J Gerontol B Psychol Sci Soc Sci 2005;60:304-12. http://dx.doi.org/10.1093/geronb/60.6.P304
228. Reis HT. The role of intimacy in interpersonal relations. J Soc Clin Psychol 1990;9:15-30. http://dx. doi.org/10.1521/jscp.1990.9.1.15
229. Nagle S, Cook JV, Polatajko HJ. I'm doing as much as I can: occupational choices of persons with a severe and persistent mental illness. J Occup Sci 2002;9:72-81. http://dx.doi.org/10.1080/ 14427591.2002.9686495
230. Romm KL, Rossberg JI, Hansen CF, Haug E, Andreasen OA, Melle I. Self-esteem is associated with premorbid adjustment and positive psychotic symptoms in early psychosis. BMC Psychiatry 2011;11:136. http://dx.doi.org/10.1186/1471-244X-11-136
231. Frank JD. Psychotherapy: the restoration of morals. Am J Psychiatry 1974;131:271-4.
232. Strada AE. Grief, demoralization and depression: diagnostic challenges and treatment modalities. Prim Psychiatry 2009;16:49-55.
233. Leamy M, Bird V, Le Boutillier C, Williams J, Slade M. A conceptual framework for personal recovery in mental health: systematic review and narrative synthesis. Br J Psychiatry 2011;199:445-52. http://dx.doi.org/10.1192/bjp.bp.110.083733
234. Anthony WA. Recovery from mental illness: the guiding vision of the mental health service system in the 1990s. Psychosoc Rehabil J 1993;16:11-23. http://dx.doi.org/10.1037/h0095655
235. Care Services Improvement Partnership, Royal College of Psychiatrists, Social Care Institute for Excellence. A Common Purpose: Recovery in Future Mental Health Services. Leeds: Social Care Institute for Excellence; 2007.
236. Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health 2012;15:118-27. http://dx.doi.org/ 10.1016/j.jval.2011.08.002
237. Qureshi H, Patmore C, Nicholas E. Overview Outcomes of Social Care for Older People and Carers. York: Social Policy Research Unit, University of York; 1998.
238. Huppert FA, Whttington JE. Evidence for the independence of positive and negative well-being: implications for quality of life assessment. Br J Health Psychol 2003;8:107-22. http://dx.doi.org/ 10.1348/135910703762879246
239. Bowling A. A taxonomy and overview of quality of life. In Brown J, Bowling A, Flynn T, editors. Models of Quality of Life: A Taxonomy and Systematic Review of the Literature. Sheffield: European Forum on Population Ageing Research Project, University of Sheffield; 2004.
240. Headey B, Kelley WJ, Wearing AJ. Dimensions of mental health: life satisfaction, positive affect, anxiety, and depression. Soc Indic Res 1993;29:63-82. http://dx.doi.org/10.1007/BF01136197
241. Deci E, Ryan RM. The 'what' and 'why' of goal pursuits: human needs and the self-determination of behavior. Psychol Inq 2000;11:319-38.
242. Maslow A. Toward a Psychology of Being. 2nd edn. New York, NY: Van Nostrand; 1968.
243. Keyes C, Shmotkin D, Ryff C. Optimizing wellbeing: the empirical encounter of two traditions. J Pers Soc Psychol 2002;82:1007-22.
244. Ryff CD. Happiness is everything, or is it? Explorations on the meaning of psychological well-being. J Pers Soc Psychol 1989;57:1069-81. http://dx.doi.org/10.1037//0022-3514.57.6.1069
245. Waterman A. The Psychology of Individualism. New York, NY: Praeger; 1984.
246. Tennant A, McKenna SP, Hagell P. Application of Rasch analysis in the development and application of quality of life instruments. Value Health 2004;7(Suppl. 1):22-26. http://dx.doi.org/ 10.1111/j.1524-4733.2004.7s106.x
247. Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, et al. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess 2014;18(9).
248. Young T, Yang Y, Brazier J, Tsuchiya A. Use of Rasch analysis in reducing a large condition specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D. Med Decis Making 2011;31:195-210. http://dx.doi.org/10.1177/0272989X10364846
249. Yang Y, Brazier J, Tsuchiya A, Young T. Estimating a preference-based index for a 5-dimensional health state classification for asthma (AQL-5D) derived from the Asthma Quality of Life Questionnaire (AQLG). Med Decis Making 2011;31:281-91.
250. Mulhern B, Smith SC, Rowen D, Brazier JE. Improving the measurement of QALYs in dementia: developing patient-and carer-reported health state classification systems using Rasch analysis. Value Health 2012;15:346-56.
251. Rowen D, Brazier J, Young T, Gaugris S, Craig BM, King MT, et al. Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 2011;14:721-31. http://dx.doi.org/ 10.1016/j.jval.2011.01.004
252. Rowen D, Mulhern B, Banerjee S, Hout BV, Young T, Knapp M, et al. Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health 2012;15:346-56. http://dx.doi.org/10.1016/j.jval.2011.10.016
253. Mavranezouli I, Brazier J, Rowen D, Barkham M. Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D. Med Decis Making 2013;33:381-95. http://dx.doi.org/10.1177/0272989X12464431